Frequency and spectrum of PIK3CA somatic mutations in breast cancer von Martínez-Sáez, Olga, Chic, Nuria, Pascual, Tomás, Adamo, Barbara, Vidal, Maria, González-Farré, Blanca, Sanfeliu, Esther, Schettini, Francesco, Conte, Benedetta, Brasó-Maristany, Fara, Rodríguez, Adela, Martínez, Débora, Galván, Patricia, Rodríguez, Ana Belén, Martinez, Antonio, Muñoz, Montserrat, Prat, Aleix

Volltext

Immune-Related Gene Expression Profiling After PD-1 Blockade in Non-Small Cell Lung Carcinoma, Head and Neck Squamous Cell Carcinoma, and Melanoma von Prat, Aleix, Navarro, Alejandro, Paré, Laia, Reguart, Noemí, Galván, Patricia, Pascual, Tomás, Martínez, Alex, Nuciforo, Paolo, Comerma, Laura, Alos, Llucia, Pardo, Nuria, Cedrés, Susana, Fan, Cheng, Parker, Joel S, Gaba, Lydia, Victoria, Iván, Viñolas, Nuria, Vivancos, Ana, Arance, Ana, Felip, Enriqueta

Volltext

Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade von Brasó-Maristany, Fara, Griguolo, Gaia, Pascual, Tomás, Paré, Laia, Nuciforo, Paolo, Llombart-Cussac, Antonio, Bermejo, Begoña, Oliveira, Mafalda, Morales, Serafín, Martínez, Noelia, Vidal, Maria, Adamo, Barbara, Martínez, Olga, Pernas, Sonia, López, Rafael, Muñoz, Montserrat, Chic, Núria, Galván, Patricia, Garau, Isabel, Manso, Luis, Alarcón, Jesús, Martínez, Eduardo, Gregorio, Sara, Gomis, Roger R., Villagrasa, Patricia, Cortés, Javier, Ciruelos, Eva, Prat, Aleix

Volltext

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer von Schettini, Francesco, Chic, Nuria, Brasó-Maristany, Fara, Paré, Laia, Pascual, Tomás, Conte, Benedetta, Martínez-Sáez, Olga, Adamo, Barbara, Vidal, Maria, Barnadas, Esther, Fernández-Martinez, Aranzazu, González-Farre, Blanca, Sanfeliu, Esther, Cejalvo, Juan Miguel, Perrone, Giuseppe, Sabarese, Giovanna, Zalfa, Francesca, Peg, Vicente, Fasani, Roberta, Villagrasa, Patricia, Gavilá, Joaquín, Barrios, Carlos H., Lluch, Ana, Martín, Miguel, Locci, Mariavittoria, De Placido, Sabino, Prat, Aleix

Volltext

HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis von Schettini, Francesco, Pascual, Tomás, Conte, Benedetta, Chic, Nuria, Brasó-Maristany, Fara, Galván, Patricia, Martínez, Olga, Adamo, Barbara, Vidal, Maria, Muñoz, Montserrat, Fernández-Martinez, Aranzazu, Rognoni, Carla, Griguolo, Gaia, Guarneri, Valentina, Conte, Pier Franco, Locci, Mariavittoria, Brase, Jan C., Gonzalez-Farre, Blanca, Villagrasa, Patricia, De Placido, Sabino, Schiff, Rachel, Veeraraghavan, Jamunarani, Rimawi, Mothaffar F., Osborne, C. Kent, Pernas, Sonia, Perou, Charles M., Carey, Lisa A., Prat, Aleix

Volltext

Clinical implications of the intrinsic molecular subtypes in hormone receptor-positive and HER2-negative metastatic breast cancer von Falato, Claudette, Schettini, Francesco, Pascual, Tomás, Brasó-Maristany, Fara, Prat, Aleix

Volltext

Landscape of neoadjuvant therapy in HER2-positive breast cancer: a systematic review and network meta-analysis von Villacampa, Guillermo, Matikas, Alexios, Oliveira, Mafalda, Prat, Aleix, Pascual, Tomás, Papakonstantinou, Andri

Volltext

Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer von Prat, Aleix, Brasó-Maristany, Fara, Martínez-Sáez, Olga, Sanfeliu, Esther, Xia, Youli, Bellet, Meritxell, Galván, Patricia, Martínez, Débora, Pascual, Tomás, Marín-Aguilera, Mercedes, Rodríguez, Anna, Chic, Nuria, Adamo, Barbara, Paré, Laia, Vidal, Maria, Margelí, Mireia, Ballana, Ester, Gómez-Rey, Marina, Oliveira, Mafalda, Felip, Eudald, Matito, Judit, Sánchez-Bayona, Rodrigo, Suñol, Anna, Saura, Cristina, Ciruelos, Eva, Tolosa, Pablo, Muñoz, Montserrat, González-Farré, Blanca, Villagrasa, Patricia, Parker, Joel S., Perou, Charles M., Vivancos, Ana

Volltext

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentr... von Prat, Aleix, Saura, Cristina, Pascual, Tomás, Hernando, Cristina, Muñoz, Montserrat, Paré, Laia, González Farré, Blanca, Fernández, Pedro L, Galván, Patricia, Chic, Núria, González Farré, Xavier, Oliveira, Mafalda, Gil-Gil, Miguel, Arumi, Miriam, Ferrer, Neus, Montaño, Alvaro, Izarzugaza, Yann, Llombart-Cussac, Antonio, Bratos, Raquel, González Santiago, Santiago, Martínez, Eduardo, Hoyos, Sergio, Rojas, Beatriz, Virizuela, Juan Antonio, Ortega, Vanesa, López, Rafael, Céliz, Pamela, Ciruelos, Eva, Villagrasa, Patricia, Gavilá, Joaquín

Volltext

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer von Cejalvo, Juan Miguel, Pascual, Tomás, Fernández-Martínez, Aranzazu, Brasó-Maristany, Fara, Gomis, Roger R., Perou, Charles M., Muñoz, Montserrat, Prat, Aleix

Volltext

Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer von Prat, Aleix, Guarneri, Valentina, Pascual, Tomás, Brasó-Maristany, Fara, Sanfeliu, Esther, Paré, Laia, Schettini, Francesco, Martínez, Débora, Jares, Pedro, Griguolo, Gaia, Dieci, Maria Vittoria, Cortés, Javier, Llombart-Cussac, Antonio, Conte, Benedetta, Marín-Aguilera, Mercedes, Chic, Nuria, Puig-Butillé, Joan Anton, Martínez, Antonio, Galván, Patricia, Tsai, Yi-Hsuan, González-Farré, Blanca, Mira, Aurea, Vivancos, Ana, Villagrasa, Patricia, Parker, Joel S., Conte, Pierfranco, Perou, Charles M.

Volltext

Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial von Ciruelos, Eva, Villagrasa, Patricia, Pascual, Tomás, Oliveira, Mafalda, Pernas, Sonia, Paré, Laia, Escrivá-de-Romaní, Santiago, Manso, Luis, Adamo, Barbara, Martínez, Eduardo, Cortés, Javier, Vazquez, Silvia, Perelló, Antonia, Garau, Isabel, Melé, Mireia, Martínez, Noelia, Montaño, Alvaro, Bermejo, Begoña, Morales, Serafin, Echarri, María J, Vega, Estela, González-Farré, Blanca, Martínez, Débora, Galván, Patricia, Canes, Jordi, Nuciforo, Paolo, Gonzalez, Xavier, Prat, Aleix

Volltext

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade von Prat, Aleix, Pascual, Tomás, De Angelis, Carmine, Gutierrez, Carolina, Llombart-Cussac, Antonio, Wang, Tao, Cortés, Javier, Rexer, Brent, Paré, Laia, Forero, Andres, Wolff, Antonio C, Morales, Serafín, Adamo, Barbara, Brasó-Maristany, Fara, Vidal, Maria, Veeraraghavan, Jamunarani, Krop, Ian, Galván, Patricia, Pavlick, Anne C, Bermejo, Begoña, Izquierdo, Miguel, Rodrik-Outmezguine, Vanessa, Reis-Filho, Jorge S, Hilsenbeck, Susan G, Oliveira, Mafalda, Dieci, Maria Vittoria, Griguolo, Gaia, Fasani, Roberta, Nuciforo, Paolo, Parker, Joel S, Conte, PierFranco, Schiff, Rachel, Guarneri, Valentina, Osborne, C Kent, Rimawi, Mothaffar F

Volltext

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response von Brasó-Maristany, Fara, Ferrero-Cafiero, Juan Manuel, Falato, Claudette, Martínez-Sáez, Olga, Cejalvo, Juan Miguel, Margelí, Mireia, Tolosa, Pablo, Salvador-Bofill, Francisco Javier, Cruz, Josefina, González-Farré, Blanca, Sanfeliu, Esther, Òdena, Andreu, Serra, Violeta, Pardo, Francisco, Luna Barrera, Ana María, Arumi, Miriam, Guerra, Juan Antonio, Villacampa, Guillermo, Sánchez-Bayona, Rodrigo, Ciruelos, Eva, Espinosa-Bravo, Martín, Izarzugaza, Yann, Galván, Patricia, Matito, Judith, Pernas, Sonia, Vidal, Maria, Santhanagopal, Anu, Sellami, Dalila, Esker, Stephen, Fan, Pang-Dian, Suto, Fumitaka, Vivancos, Ana, Pascual, Tomás, Prat, Aleix, Oliveira, Mafalda

Volltext

Gene expression profiles of breast cancer metastasis according to organ site von Brasó‐Maristany, Fara, Paré, Laia, Chic, Nuria, Martínez‐Sáez, Olga, Pascual, Tomás, Mallafré‐Larrosa, Meritxell, Schettini, Francesco, González‐Farré, Blanca, Sanfeliu, Esther, Martínez, Débora, Galván, Patricia, Barnadas, Esther, Salinas, Belinda, Tolosa, Pablo, Ciruelos, Eva, Carcelero, Esther, Guillén, Cecilia, Adamo, Barbara, Moreno, Reinaldo, Vidal, Maria, Muñoz, Montserrat, Prat, Aleix

Volltext

Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial von Adamo, Barbara, Bellet, Meritxell, Paré, Laia, Pascual, Tomás, Vidal, Maria, Pérez Fidalgo, José A, Blanch, Salvador, Martinez, Noelia, Murillo, Laura, Gómez-Pardo, Patricia, López-González, Ana, Amillano, Kepa, Canes, Jordi, Galván, Patricia, González-Farré, Blanca, González, Xavier, Villagrasa, Patricia, Ciruelos, Eva, Prat, Aleix

Volltext

Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer von Lorman-Carbó, Natàlia, Martínez-Sáez, Olga, Fernandez-Martinez, Aranzazu, Galván, Patricia, Chic, Nuria, Garcia-Fructuoso, Isabel, Rodríguez, Adela, Gómez-Bravo, Raquel, Schettini, Francesco, Blasco, Paula, Castillo, Oleguer, González-Farré, Blanca, Adamo, Barbara, Vidal, Maria, Muñoz, Montserrat, Perou, Charles M., Malumbres, Marcos, Gavilá, Joaquín, Pascual, Tomás, Prat, Aleix, Brasó-Maristany, Fara

Volltext

Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance von Waks, Adrienne G., Martínez-Sáez, Olga, Tarantino, Paolo, Braso-Maristany, Fara, Pascual, Tomás, Cortés, Javier, Tolaney, Sara M., Prat, Aleix

Volltext

Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement von Colomer, Ramon, Saura, Cristina, Sánchez‐Rovira, Pedro, Pascual, Tomás, Rubio, Isabel T., Burgués, Octavio, Marcos, Lourdes, Rodríguez, César A., Martín, Miguel, Lluch, Ana

Volltext

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment? von Cejalvo, Juan Miguel, Falato, Claudette, Villanueva, Lorea, Tolosa, Pablo, González, Xavier, Pascal, Mariona, Canes, Jordi, Gavilá, Joaquín, Manso, Luis, Pascual, Tomás, Prat, Aleix, Salvador, Fernando

Volltext